Research study to evaluate an investigational immunotherapy for advanced prostate cancer - BMS CA184043
Protocol Title Cancer - Prostate - Research study to evaluate an investigational immunotherapy for advanced prostate cancer - BMS CA184043
Summary This research study is designed to determine if an investigational agent, known as ipilimumab, is safe and effective for advanced prostate cancer when it is given after radiotherapy. Ipilimumab is currently approved by the United States Food and Drug Administration (FDA) and other Health Authorities for the treatment of newly diagnosed or previously-treated unresectable metastatic melanoma.

Ipilimumab is an immunotherapeutic agent that is intended to "turn on" your immune system which may allow your immune system to attack and kill cancer cells.

About 800 patients throughout the world, approximately 300 in the United States, are expected to participate in this study. Participants may be in the study for 1 year or more, depending on how they respond to the study therapy.

Participants in this trial may receive, at no cost, study-related: medical care, study medication, laboratory work and evaluations.

Medical insurance is not necessary to participate in this study, and study-related travel/parking may be reimbursed.
Therapeutic Area Cancer - Prostate
Age Range Minimum Age : 18
Purpose This trial is designed to determine if advanced prostate cancer patients that are treated with radiotherapy plus the investigational drug ipilimumab live longer than those treated with radiotherapy and supportive care.
Who is Eligible? To participate you must:
  • have a diagnosis of prostate cancer that has metastasized to the bone
  • have previously undergone at least 1 chemotherapy regimen containing docetaxel (Taxotere)
  • A study physician will discuss complete study criteria with you

If you are interested in determining if you are eligible to participate in this important clinical trial:

If already registered, login







If not a registered member, Register now for Free


First Name
Last Name
Email
Phone
Zip
Trial Interests Allergies/Asthma
Alzheimer's Disease
Arthritis
Cancer
Cancer - Breast
Cancer - Head and Neck
Cancer - Lung
Cancer - Pancreatic
Cancer - Prostate
COPD/Emphysema
Crohn's Disease
Cystic Fibrosis
Depression
Diabetes
Epilepsy
Fibromyalgia
Healthy Volunteers
Heart Disease
Low Back Pain
Lupus
Men's Health
Menopause
Multiple Sclerosis
Other
Parkinson's
Pediatric Health
Peripheral Arterial Disease (PAD)
Vascular Disease
User Name
Password
Confirm Password
Trial Notification Opt In yes = Please email me updates on my preferred clinical trials





Trial Locations per State
LocationStateAddress

Trial Materials and Media

Videos


Click thumbnail to view video:

Images

Click to enlarge the map and find the trial site nearest to you
Click to Enlarge -- You may qualify to participate in this trial - Register as a patient and answer the pre-screening questions

Printed Material

Being a caregiver is an important job - read our borchure on caregiving
Click to enlarge
Learn more about the design of this trial and the use of placebo
Click to enlarge

Your Name:
Your Email:
Friend's Name:
Friend's Email:
Print This Trial